- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.03. | CareMax, Inc. (CMAX) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
| 19.03. | Earnings call: CareMax outlines strategic shifts amid sector headwinds | 1 | Investing.com | ||
| 18.03. | CareMax reports Q4 results | 1 | Seeking Alpha | ||
| 18.03. | CareMax Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 18.03. | CareMax Slips To Q4 Loss On Higher Charges, Weak Revenues; Explores Strategic Options | 2 | RTTNews | ||
| 18.03. | CareMax, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.03. | CareMax Reports Fourth Quarter and Full Year 2023 Results | 98 | Business Wire | MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the... ► Artikel lesen | |
| 18.03. | CareMax, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 18.03. | CareMax, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 12.03. | Renalytix, CareMax, TC BioPharm among healthcare movers | 9 | Seeking Alpha | ||
| 26.02. | CareMax stock downgraded to hold, yet price target boosted to $7.50 | 2 | Investing.com | ||
| 05.02. | CareMax, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.01. | CareMax announces 1-for-30 reverse stock split of its class A common stock | 1 | Seeking Alpha | ||
| 29.01. | CareMax, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.01. | CareMax Announces 1-for-30 Reverse Stock Split | 153 | Business Wire | MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced that the Company's Board... ► Artikel lesen | |
| 11.01. | CareMax, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.11.23 | CareMax, Inc. (CMAX) Q3 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 10.11.23 | CareMax cut as Piper Sandler 'cannot continue to recommend the stock' | 1 | Investing.com | ||
| 09.11.23 | CareMax, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.11.23 | CareMax GAAP EPS of -$0.92 misses by $0.80, revenue of $201.8M beats by $4.89M | 2 | Seeking Alpha |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 352,00 | -0,07 % | Quartalszahlen: China sei Dank: Intuitive Surgical übertrifft Erwartungen, Aktie steigt! | © Foto: Frank Molter - picture allianceDie Aktie des Herstellers von Medizinrobotern Intuitive Surgical ist nach guten Quartalszahlen gefragt und steigt.Erholung in China ließ lange auf sich warten... ► Artikel lesen | |
| ROKU | 58,00 | +0,54 % | Hemisphere Media Group Launches WAPA+ on the Roku Channel | ||
| ATOSSA THERAPEUTICS | 1,366 | -1,58 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| ORPEA | 12,482 | -1,48 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| QUIDELORTHO | 36,600 | -3,17 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| VERU | 1,220 | +2,43 % | LI, VERU and MRIN among pre-market losers | ||
| TEMPEST THERAPEUTICS | 3,150 | -1,32 % | Tempest Therapeutics: Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications | TPST-1120, a first-in-class, oral, selective PPAR? antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent positive randomized data... ► Artikel lesen | |
| CENTENE | 71,17 | +0,44 % | Centene-Aktie legt um 0,84 Prozent zu (71,0929 €) | Im Plus liegt aktuell das Wertpapier von Centene . Das Papier kostete zuletzt 75,78 US-Dollar. Heute hat sich an der US-amerikanischen Börse die Centene-Aktie zwischenzeitlich um 0,84 Prozent verteuert.... ► Artikel lesen | |
| NANO-X IMAGING | 9,290 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| PERSPECTIVE THERAPEUTICS | 1,610 | +1,26 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results | SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout... ► Artikel lesen | |
| LANTHEUS | 60,74 | +0,93 % | Lantheus Holdings, Inc.: Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time | ||
| OMNICELL | 26,200 | -1,50 % | Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 52,50 | 0,00 % | AMN Healthcare Services Inc: Survey: Physicians Turning to Locum Tenens to Improve Work Conditions, Relieve Burnout | ||
| BUTTERFLY NETWORK | 0,740 | 0,00 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen |
Das Unternehmen CAREMAX INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 3,460 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
